Table 4.
Variable | Category | HR (95 % CI) | p value |
---|---|---|---|
Age | Cont. Var. | 1.040 (0.996–1.086) | 0.075 |
Sex | Male versus female | 1.018 (0.647–1.600) | 0.939 |
BMI | Cont. Var. | 0.912 (0.859–0.968) | 0.002 |
ADL | Cont. Var. | 0.920 (0.751–1.128) | 0.423 |
IADL | Cont. Var. | 1.008 (0.870–1.167) | 0.92 |
Comorbidity index CIRS | Cont. Var. | 0.914 (0.749–1.114) | 0.372 |
MMSE | <24 versus ≥24 | 0.971 (0.595–1.584) | 0.906 |
Psychiatric diseases | Yes versus no | 0.498 (0.198–1.251) | 0.138 |
Cancer stage | IV versus I | 6.689 (2.950–15.166) | <0.001 |
III versus I | 2.129 (0.854–5.306) | 0.105 | |
II versus I | 3.335 (1.389–8.009) | 0.007 | |
Cancer treatment | Yes versus no | 0.984 (0.618–1.567) | 0.945 |
No of drugs | Cont. Var. | 1.023 (0.923–1.133) | 0.668 |
ECOG performance status | ≥3 versus 0 | 7.747 (1.744–34.411) | 0.007 |
2 versus 0 | 3.827 (1.777–8.244) | <0.001 | |
1 versus 0 | 3.122 (1.877–5.191) | <0.001 | |
Caregiver | Yes versus no | 1.193 (0.708–2.010) | 0.508 |
15-item Geriatric Depression Scale | >5 versus ≤5 | 0.947 (0.574–1.564) | 0.833 |
Syndromes | Yes versus no | 1.050 (0.494–2.234) | 0.898 |
Tumor site | Breast versus other | 0.164 (0.068–0.396) | <0.001 |
Colorectal versus other | 0.379 (0.214–0.671) | <0.001 | |
Lung versus other | 1.407 (0.767–2.579) | 0.270 | |
Prostate versus other | 0.209 (0.073–0.599) | 0.004 | |
Other genitourinary versus other | 1.260 (0.652–2.433) | 0.492 |
BMI body mass index, ADL activities of daily living, IADL instrumental activities of daily living, CIRS Cumulative Illness Rating Scale, MMSE mini-mental state examination, ECOG Eastern Cooperative Oncology Group, Cont. Var. continuous variable